BioHealth News
Qnovia Enters Collaboration with University of Virginia to Advance Inhaled Drug Candidates for Treating Infectious Diseases
RICHMOND, Va.--(BUSINESS WIRE)-- Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas, today announced it has entered into a…
Read More
Baltimore’s MyMD Announces Preclinical Study Results Showing Novel Cannabidiol Analog, Supera-CBD™, Reduced Acute Inflammatory Pain
- Supera-CBD eased heat-related pain due to inflammation quickly and provided long-lasting pain relief lasting up to five hours - Results suggest Supera-CBD may target specific…
Read More
Maryland Industrial Partnerships (MIPS) Program Provides Matching Grants for 17 Technology Development Projects Teaming Maryland Companies, USM Faculty
The Maryland Industrial Partnerships (MIPS) program announced that it is providing matching grants for 17 technology product development projects in Maryland. Each project pairs University System…
Read More
Ascentage Pharma and AstraZeneca Enter into Clinical Collaboration
Ascentage Pharma and AstraZeneca Enter into Clinical Collaboration on the Registrational Phase III Study of Bcl-2 Inhibitor Lisaftoclax in Combination with BTK Inhibitor Acalabrutinib…
Read More
BioTalk – Revolutionizing Autoimmune Medicine: MyMD Pharmaceuticals Innovative Therapies
Are you interested in exploring cutting-edge autoimmune medicines? In this episode of BioTalk with Rich Bendis, we're delving deep into the world of transformative…
Read More
Governor Moore Spotlights Biotechnology and Economic Development During Visit to University of Maryland BioPark
Published: 10/10/2023 ANNAPOLIS, MD — Governor Wes Moore today visited the University of Maryland BioPark for a discussion and tour focused on biotechnology, innovation and…
Read More
IndoUSrare Announces Bridging RARE Summit to Combat Rare Diseases by Fostering Cross-Border Collaborations, Data Sharing, and Clinical Trials
With an increasing number of U.S. biopharmaceutical firms feeling the financial constraints imposed by the Inflation Reduction Act (IRA) and subsequently shutting down or…
Read More
Emmes Acquires VaxTRIALS
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth Rockville, MD, October 5, 2023 – Emmes, a global, full-service Clinical Research…
Read More
Maryland based United Therapeutics is leading a medical revolution
Imagine a world where unhealthy organs are replaced with transplants constructed with a 3D printer using the patient’s own cells. No more agonizing waits…
Read More
Navigating 2023’s BioPharma Clusters with Alex Philippidis
Alex Philippidis, Senior Business Editor of Genetic Engineering and Biotechnology News, for the 4th consecutive year, attended the 9th Annual BioHealth Capital Region Forum,…
Read More
Unveiling Key Insights with Pete Briskman: A Comprehensive Update on the BioHealth Capital Region
In the 9th Annual BioHealth Capital Region Forum, Pete Briskman, Executive Managing Director and Co-Lead for the Mid-Atlantic Life Sciences Practice, offered a thorough…
Read More
Amgen Completes Acquisition of Horizon Therapeutics PLC
Advances Amgen's Mission to Serve Patients With First-in-Class Rare Disease Medicines THOUSAND OAKS, Calif., Oct. 6, 2023 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it has completed its acquisition…
Read More
Revisiting Rich Bendis’s Welcome at the 9th Annual BioHealth Capital Region Forum
In a year that underscored “Global Breakthroughs for a Healthier Future,” Rich Bendis, President and CEO of BioHealth Innovation Inc (BHI), extended a heartfelt…
Read More
BioHealth Innovation, Inc. Announces Strategic Agreement to Provide ARPA-H with Entrepreneurs-in-Residence
ROCKVILLE, MARYLAND, October 5, 2023 – BioHealth Innovation, Inc. (BHI) is proud to announce a pivotal agreement with the Advanced Research Projects Agency for…
Read More
Gain Therapeutics Announces Dosing of First Two Subjects in Phase 1 Clinical Trial of GT-02287, a Novel GCase-targeting Small Molecule Therapy for GBA1 Parkinson’s Disease
First small molecule allosteric binder discovered with Gain’s computational drug discovery platform enters clinical developmentBETHESDA, Md., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics,…
Read More